Access to treatment for Hepatitis C among injection drug users: results from the cross-sectional HOPE IV study.
Souliotis KyriakosEirini AgapidakiManto PapageorgiouNiki VoudouriXenophon ContiadesPublished in: International journal for equity in health (2017)
The findings from the present study revealed that the vast majority of IDUs experience significant barriers in seeking HCV care in Greece, thus highlighting the need for immediate action in this particular area due to the high risk of co-infection and transmission.